Lan Coffman

Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer

Kathleen N. Moore, Antoine Angelergues, Gottfried E. Konecny et al. · New England Journal of Medicine · 2023 · 414 citations · Full text

Medicine, Oncology, Pharmacology +16

B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinoma

Ayana T. Ruffin, Anthony R. Cillo, Tracy Tabib et al. · Nature Communications · 2021 · 358 citations · Full text

Life Sciences, Immunology, Oncology +17

An Iron Regulatory Gene Signature Predicts Outcome in Breast Cancer

Lance D. Miller, Lan Coffman, Jeff W. Chou et al. · Cancer Research · 2011 · 213 citations · Full text

Medicine, Cancer Biology, Oncology +17

Phase II clinical trial of metformin as a cancer stem cell–targeting agent in ovarian cancer

Jason R. Brown, Daniel Chan, Jessica Shank et al. · JCI Insight · 2020 · 191 citations · Full text

Medicine, Oncology, Pharmacology +14

Regulatory effects of ferritin on angiogenesis

Lan Coffman, Derek Parsonage, Ralph B. D’Agostino et al. · Proceedings of the National Academy of Sciences · 2009 · 166 citations · Full text

Medicine, Cancer Biology, Oncology +11